Drug Profile
Oxycodone immediate release - Purdue
Alternative Names: OxiFast; OxiNorm; OxyFast; OxyGesic; OxyIR; OxylR; OxyNorm; S-8116; S-8117; S-811717Latest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Purdue Pharma
- Developer Mundipharma International; Napp Pharmaceutical Group; Purdue Pharma; Shionogi
- Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer pain; Pain
- Phase III Postoperative pain
- No development reported Back pain
Most Recent Events
- 17 Apr 2021 No development reported - Phase-III for Back pain in Japan (PO) (Shionogi pipeline April 2021)
- 17 Apr 2021 No development reported - Phase-III for Pain in Japan (PO) (Shionogi pipeline April 2021)
- 05 Jun 2018 Phase III clinical trials for Pain in Japan (PO) (JapicCTI-183986)